CHICAGO, June 3 — Two prominent prostate cancer experts have received threats because of their opposition to approval of a new drug, officials attending the conference of the the American Society of Clinical Oncology said Sunday.
The experts, Dr. Howard I. Scher of Memorial Sloan-Kettering Cancer Center and Dr. Maha Hussain of the University of Michigan, received e-mail and other threats, spokeswomen for Sloan-Kettering and for the cancer conference said.
It is not known who sent the threats. But the doctors’ public stance against the drug, Provenge, has angered some men with prostate cancer and patient advocates.
No comments:
Post a Comment